Neuropeptide Y Y2 Receptors in Hypothalamic Neuroendocrine Areas Are Up-Regulated by Estradiol and Decreased by Progesterone Cotreatment in the Ovariectomized Rat

Endocrinology

Volumn 137, Issue 7, 1996, Pages 2896-2900

  Parker, S L ^a   Carroll, B L ^a   Kalra, S P ^b   St Pierre, S ^c   Fournier, A ^c   Crowley, W R ^a  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c INSTITUT NATIONAL DE LA RECHERCHE SCIENTIFIQUE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; LUTEINIZING HORMONE; NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y2 RECEPTOR; PEPTIDE; PEPTIDE YY; PROGESTERONE; PROLACTIN; RECOMBINANT PROTEIN; GONADORELIN;

ANALYSIS OF VARIANCE; ANIMAL; ANTERIOR HYPOTHALAMUS; ANTIBODY SPECIFICITY; ARTICLE; BIOSYNTHESIS; BLOOD; DOWN REGULATION; DRUG EFFECT; DRUG INTERACTION; FEMALE; HUMAN; HYPOTHALAMUS; METABOLISM; OVARIECTOMY; POINT MUTATION; PREOPTIC AREA; RAT; UPREGULATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; CONTROLLED STUDY; GONADORELIN RELEASE; HORMONAL REGULATION; HORMONE RECEPTOR INTERACTION; LUTEINIZING HORMONE RELEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PYRIFORM CORTEX; RECEPTOR UPREGULATION; TISSUE DISTRIBUTION;

ANALYSIS OF VARIANCE; ANIMALS; DOWN-REGULATION; DRUG INTERACTIONS; ESTRADIOL; FEMALE; HUMANS; HYPOTHALAMUS; HYPOTHALAMUS, ANTERIOR; HYPOTHALAMUS, MIDDLE; LUTEINIZING HORMONE; ORGAN SPECIFICITY; OVARIECTOMY; PEPTIDE YY; PEPTIDES; POINT MUTATION; PREOPTIC AREA; PROGESTERONE; PROLACTIN; RATS; RECEPTORS, NEUROPEPTIDE Y; RECOMBINANT PROTEINS; UP-REGULATION;

EID: 0029665046     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.137.7.8770911     Document Type: Article

References (40)

1. Kalra SP, Crowley WR 1992 Neuropeptide Y: a novel neuroendocrine peptide in the control of pituitary hormone secretion, and its relation to luteinizing hormone. Front Neuroendocrinol 13:1-46
2. Lee WS, Smith MS, Hoffman GE 1990 Progesterone enhances the surge of luteinizing hormone by increasing the activation of luteinizing hormone-releasing hormone neurons. Endocrinology 127:2604-2606
3. Sahu A, Crowley WR, Kalra SP 1990 An opioid-neuropeptide-Y transmission line to luteinizing hormone (LH)-releasing hormone neurons: a role in the induction of LH surge. Endocrinology 126: 876-883
4. Sahu A, Crowley WR, Kalra SP 1994 Hypothalamic neuropeptide-Y gene expression increases before the onset of the ovarian steroid-induced luteinizing hormone surge. Endocrinology 134:1018-1022
5. Emons G, Nill J, Sturm R, Ortmann O 1992 Effects of progesterone on gonadotropin-releasing hormone receptor concentration in cultured estrogen-primed female rat pituitary cells. J Steroid Biochem Mol Biol 42:831-839
6. Kalra SP, Fuentes M, Fournier A, Parker SL, Crowley WR 1992 Involvement of the Y-1 receptor subtype in the regulation of luteinizing hormone secretion by neuropeptide Y in rats. Endocrinology 130:3323-3330
7. Parker SL, Sweatman T, Carroll BL, Crowley WR, Characterization of neuropeptide Y (NPY) receptors in rat brain areas: subtype-related differences in affinity and sensitivity to ions, chaotropic agents and guanine nucleotides. 25th Annual Meeting of the Society for Neuroscience, San Diego CA, 1995 (Abstract 402.1)
8. Butcher RL, Collins WE, Fugo NW 1974 Plasma concentration of LH, FSH, prolactin, progesterone and estradiol-17β throughout the 4-day estrous cycle of the rat. Endocrinology 94:1704-1708
9. Kalra SP, Kalra PS 1974 Temporal interrelationships among circulating levels of estradiol, progesterone and LH during the rat estrous cycle: effects of exogenous progesterone. Endocrinology 95:1711-1718
10. Paxinos G, Watson C 1986 The Rat Brain in Stereotaxic Coordinates. Academic Press, San Diego
11. Parker SL, Crowley WR 1993 Central stimulation of oxytocin release in the lactating rat: interaction of neuropeptide Y with α-1-adrenergic mechanisms. Endocrinology 132:658-666
12. Parker SL, Kalra SP, Crowley WR 1991 Neuropeptide Y modulates the binding of a gonadotropin-releasing hormone (GnRH) analog to anterior pituitary GnRH receptor sites. Endocrinology 128:2309-2316
13. 34]peptide YY is a Y1-selective agonist at peptide YY / neuropeptide Y receptors. Eur J Pharmacol 269:127-132
14. Dumont Y, Fournier A, St-Pierre S, Quirion R 1995 Characterization of neuropeptide Y binding sites in rat brain membrane preparations using [1-125][Leu(31),Pro(34)]peptide YY and [I-125]peptide YY3-36 as selective Y-1 and Y-2 radioligands. J Pharmacol Exp Ther 272:673-680
15. Pinnaduwage PD, Bhavanandan VP, Davidson EA 1986 Characteristics of two wheat germ agglutinin-resistant variants of B16 mouse melanoma cells with reduced tumorigenicity. Carbohydr Res 151:37-50
16. Hotchkiss J, Atkinson LE, Knobil E 1971 Time course of serum estrogen and luteinizing hormone (LH) concentrations during the menstrual cycle of the rhesus monkey. Endocrinology 89:177-183
17. Munson PJ, Rodbard D 1980 LIGAND: a versatile computerized approach for characterization of ligand-binding proteins. Anal Biochem 107:220-239
18. Zar JH 1984 Biostatistical Analysis. Interscience, Englewood Cliffs
19. Bard JA, Walker MW, Branchek TA, Weinshank TL 1995 Cloning and functional expression of a human Y4 subtype receptor for pancreatic polypeptide, neuropeptide Y, and peptide YY. J Biol Chem 270:26762-26765
20. Wahlestedt C, Regunathan S, Reis DJ 1992 Identification of cultured cells selectively expressing Y1-, Y2-, or Y3-type receptors for neuropeptide Y/peptide YY. Life Sci 50:L7-L12
21. Dumont Y, Cadieux A, Pheng LH, Fournier A, St-Pierre S, Quirion R 1994 Peptide YY derivatives as selective neuropeptide Y/peptide YY Y-1 and Y-2 agonists devoided of activity for the Y-3 receptor sub-type. Mol Brain Res 26:320-324
22. Klangkalya B, Chan A 1988 Inhibition of hypothalamic and pituitary muscarinic receptor binding by progesterone. Neuroendocrinology 47:294-302
23. Caligaris L, Astrada JJ, Taleisnik S 1968 Stimulating and inhibiting effects of progesterone on the release of luteinizing hormone. Acta Endocrinol (Copenh) 59:177-185
24. Simpkins JW, Huang HH, Advis JP, Meites J 1979 Changes in hypothalamic NE and DA turnover rates resulting from steroid-induced LH and prolactin surges in ovariectomized rats. Biol Reprod 20:625-632
25. Wise PM, Camp-Grossman P, Barraclough CA 1981 Effects of estradiol and progesterone on plasma gonadotropins, prolactin, and LHRH in specific brain areas of ovaricctomized rats. Biol Reprod 24:820-830
26. Crowley WR, Tessel RE, O'Donohue TL, Adler BA, Kalra SP 1985 Effects of ovarian hormones on the concentrations of immunoreactive neuropeptide Y in discrete brain regions of the female rat: correlation with serum LH and median eminence LHRH. Endocrinology 117:1151-1155
27. Tischkau SA, Ramirez VD 1993 A specific membrane binding protein for progesterone in rat brain. Sex differences and induction by estrogen. Proc Natl Acad Sci USA 90:1285-1289
28. Saini KS, Summerhayes IC, Thomas P 1990 Molecular events regulating messenger RNA stability in eukaryotes. Mol Cell Biochem 96:15-23
29. Potter EK, Barden JA, McCloskey MJD, Selbie LA, Tseng A, Herzog H, Shine J 1994 A novel neuropeptide Y analog, N-acetyl[Leu(28),Leu(31)]neuropeptide Y-(24-36), with functional specificity for the presynaptic (Y-2) receptor. Eur J Pharmacol 267: 253-262
30. Shigeri Y, Fujimoto M 1994 Y2 receptors for neuropeptide Y are coupled to three intracellular signal transduction pathways in a human neuroblastoma cell line. J Biol Chem 269:8842-8848
31. Wahlestedt C, Reis DJ 1993 Neuropeptide Y-related peptides and their receptors- are the receptors potential therapeutic drug targets? Annu Rev Pharmacol Toxicol 32:309-352
32. Chen XL, Westfall TC 1994 Modulation of intracellular calcium, transients and dopamine release by neuropeptide Y in PC-12 cells. Am J Physiol 266:C784-C793
33. Greber S, Schwarzer C, Sperk G 1994 Neuropeptide Y inhibits potassium-stimulated glutamate release through Y-2 receptors in rat hippocampal slices in vitro. Br J Pharmacol 113:737-740
34. Blasquez C, Jegou S, Tranchand-Bunel D, Fournier A, Vaudry H 1992 Neuropeptide Y inhibits alpha-MSH release from rat hypothalamic slices through a pertussis toxin-sensitive G protein. Brain Res 596:163-168
35. Crowley WR, Kalra SP 1987 Neuropeptide Y stimulates the release of luteinizing hormone-releasing hormone from medial basal hypothalamus in vitro modulation by ovarian hormones. Neuroendocrinology 46:97-103
36. Li SY, Hong M, Fournier A, St-Pierre S, Pelletier G 1994 Role of neuropeptide Y in the regulation of gonadotropin-releasing hormone gene expression in the rat preoptic area. Mol Brain Res 26: 69-73
37. Allen LG, Crowley WR, Kalra SP 1987 Interactions between neuropeptide Y and adrenergic systems in the stimulation of luteinizing hormone release in steroid-primed ovariectomized rats. Endocrinology 121:1953-1959
38. 1-adrenergic involvement in neuropeptide Y-stimulated GnRH release in female rabbits. Neuroendocrinology 53:480-486
39. Perez J, Luquin S, Naftolin F, Garcia-Segura LM 1993 The role of estradiol and progesterone in phased synaptic remodelling of the rat arcuate nucleus. Brain Res 608:38-44
40. Kohama SG, Goss JR, McNeill TH, Finch CE 1995 Glial fibrillary acidic protein mRNA increases at proestrus in the arcuate nucleus of mice. Neurosci Lett 183:164-166